Follow Cbonds

Contact us (+ 7 (921) 446-25-10)
Texting is available for authorized users.
Please register or log in at the website.
Your request for online training has been sent. Cbonds managers will be in touch with you shortly. Thank you!

Halozyme Therapeutics — bonds & company profile

company Halozyme Therapeutics
full company name Halozyme Therapeutics, Inc.
country of risk USA
country of registration USA
industry Healthсare
web http://www.halozyme.com

Company details

  • pre-LEI / LEI
  • CIK


Halozyme Therapeutics, Inc., a biotechnology company, researches, develops, and commercializes human enzymes and other drug candidates in the United States, Switzerland, and internationally.

Outstanding bond issues amount

Сurrency Outstanding bond issues Cumulative volume
USD 1 460 000 000


Issue Volume, mln Status
Halozyme Therapeutics, 1.25% 1dec2024, USD (Conv.) 460 USD outstanding
Cbonds is a global fixed income data platform
  • Cbonds is a global data platform on bond market
  • Coverage: more than 170 countries and 250,000 domestic and international bonds
  • Various ways to get data: descriptive data and bond prices - website, xls add-in, mobile app
  • Analytical functionality: bond market screener, Watchlist, market maps and other tools